Ceftriaxone and Atrovent drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ceftriaxone (ceftriaxone sodium) and Atrovent (ipratropium bromide). Common drug interactions include acute coronary syndrome among females and abdominal distension among males.
The phase IV clinical study analyzes what interactions people have when they take Ceftriaxone and Atrovent. It is created by eHealthMe based on reports of 735 people who take the same drugs from the FDA, and is updated regularly.
What is Ceftriaxone?
Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.
What is Atrovent?
Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
735 people who take Ceftriaxone and Atrovent together, and have interactions are studied.
What are the common drug interactions of Ceftriaxone and Atrovent, by gender? *
What are the common drug interactions of Ceftriaxone and Atrovent, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Ceftriaxone and Atrovent?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ceftriaxone (40,991 reports)
- Atrovent (33,210 reports)
Browse all drug interactions of Ceftriaxone and Atrovent:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ceftriaxone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Atrovent:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ceftriaxone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Atrovent and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ceftriaxone sodium and ipratropium bromide (the active ingredients of Ceftriaxone and Atrovent, respectively), and Ceftriaxone and Atrovent (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Orencia vs. Vicodin, side effect and effectiveness comparison - a second ago
- Could Glimepiride cause Carotid Artery Stenosis? - 4 seconds ago
- Lung Neoplasm Malignant and Thrombocytopenia - 5 seconds ago
- Metastatic Malignant Melanoma and Conjunctivitis - 11 seconds ago
- Could Humalog Kwikpen cause Hospitalisation? - 14 seconds ago
- Intervertebral Disc Protrusion and Weight Decreased - 19 seconds ago
- Drug interactions of Rivaroxaban and Rifaximin - 29 seconds ago
- Could Gabapentin cause Hypothalamo-Pituitary Disorder? - 29 seconds ago
- Hypersensitivity and Wrist Fracture - 29 seconds ago
- Hypertonic Bladder and Gastritis - 32 seconds ago